898538-48-2

Upstream product

• 7355-22-8 5-bromo-4-hydroxysalicylic acid 
• 100-39-0 benzyl bromide 
• 912545-14-3 benzyl 2,4-bis(benzyloxy)-5-bromobenzoate 
• 912545-10-9 2,4-bis(benzyloxy)-5-bromobenzoic acid 

Downstream Products

• 898538-49-3 2,4-bis-benzyloxy-5-bromo-benzaldehyde 
• 1174007-94-3 N-(1-methyl-1H-indol-5-yl)-N''-(2,4-bis-benzyloxy-5-bromo-benzylidene)-semicarbazide 
• 959838-30-3 5-(2,4-bis-benzyloxy-5-bromo-phenyl)-4-(1-methyl-1H-indol-5-yl)-4H-[1,2,4]triazol-3-ol 

Relevant academic research and scientific papers

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.

1-THIO-D-GLUCITOL DERIVATIVES

The present invention provides a 1-thio-D-glucitol compound of the following formula, which shows the action of inhibiting the activity of SGLT2, a pharmaceutically acceptable salt of the compound, or a hydrate of the compound or the salt; and a pharmaceu